Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Computer-Aided Experiment Planning toward Causal Discovery in Neuroscience.

Matiasz NJ, Wood J, Wang W, Silva AJ, Hsu W.

Front Neuroinform. 2017 Feb 13;11:12. doi: 10.3389/fninf.2017.00012.

2.

Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function.

Berryer MH, Chattopadhyaya B, Xing P, Riebe I, Bosoi C, Sanon N, Antoine-Bertrand J, Lévesque M, Avoli M, Hamdan FF, Carmant L, Lamarche-Vane N, Lacaille JC, Michaud JL, Di Cristo G.

Nat Commun. 2016 Nov 9;7:13340. doi: 10.1038/ncomms13340.

3.

Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.

Deraredj Nadim W, Chaumont-Dubel S, Madouri F, Cobret L, De Tauzia ML, Zajdel P, Bénédetti H, Marin P, Morisset-Lopez S.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12310-12315.

PMID:
27791021
4.

NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.

Xie K, Colgan LA, Dao MT, Muntean BS, Sutton LP, Orlandi C, Boye SL, Boye SE, Shih CC, Li Y, Xu B, Smith RG, Yasuda R, Martemyanov KA.

Curr Biol. 2016 Nov 21;26(22):2992-3003. doi: 10.1016/j.cub.2016.09.010.

PMID:
27773571
5.

GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.

Violante IR, Patricio M, Bernardino I, Rebola J, Abrunhosa AJ, Ferreira N, Castelo-Branco M.

Neurology. 2016 Aug 30;87(9):897-904. doi: 10.1212/WNL.0000000000003044.

6.

Perturbed proteostasis in autism spectrum disorders.

Louros SR, Osterweil EK.

J Neurochem. 2016 Dec;139(6):1081-1092. doi: 10.1111/jnc.13723. Review.

7.

Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.

Kim KC, Gonzales EL, Lázaro MT, Choi CS, Bahn GH, Yoo HJ, Shin CY.

Biomol Ther (Seoul). 2016 May 1;24(3):207-43. doi: 10.4062/biomolther.2016.061. Review.

8.

A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.

Bearden CE, Hellemann GS, Rosser T, Montojo C, Jonas R, Enrique N, Pacheco L, Hussain SA, Wu JY, Ho JS, McGough JJ, Sugar CA, Silva AJ.

Ann Clin Transl Neurol. 2016 Feb 22;3(4):266-79. doi: 10.1002/acn3.288.

9.

Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.

Garcia MA, Solomon DA, Haas-Kogan DA.

Future Oncol. 2016 Jun;12(12):1493-506. doi: 10.2217/fon-2016-0039. Review.

PMID:
27072750
10.

mTOR, a Potential Target to Treat Autism Spectrum Disorder.

Sato A.

CNS Neurol Disord Drug Targets. 2016;15(5):533-43.

11.

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.

King LB, Koch M, Murphy KR, Velazquez Y, Ja WW, Tomchik SM.

G3 (Bethesda). 2016 Apr 7;6(4):1083-93. doi: 10.1534/g3.115.026484.

12.

Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex.

Xing L, Larsen RS, Bjorklund GR, Li X, Wu Y, Philpot BD, Snider WD, Newbern JM.

Elife. 2016 Feb 5;5. pii: e11123. doi: 10.7554/eLife.11123.

13.

New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences.

Peñagarikano O.

Exp Neurobiol. 2015 Dec;24(4):301-11. doi: 10.5607/en.2015.24.4.301. Review.

14.

Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients.

Zimerman M, Wessel MJ, Timmermann JE, Granström S, Gerloff C, Mautner VF, Hummel FC.

EBioMedicine. 2015 Sep 1;2(10):1430-7. doi: 10.1016/j.ebiom.2015.08.036.

15.

Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides.

Sztainberg Y, Chen HM, Swann JW, Hao S, Tang B, Wu Z, Tang J, Wan YW, Liu Z, Rigo F, Zoghbi HY.

Nature. 2015 Dec 3;528(7580):123-6. doi: 10.1038/nature16159.

16.

Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition.

Rivero O, Selten MM, Sich S, Popp S, Bacmeister L, Amendola E, Negwer M, Schubert D, Proft F, Kiser D, Schmitt AG, Gross C, Kolk SM, Strekalova T, van den Hove D, Resink TJ, Nadif Kasri N, Lesch KP.

Transl Psychiatry. 2015 Oct 13;5:e655. doi: 10.1038/tp.2015.152.

17.

Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Tomson SN, Schreiner MJ, Narayan M, Rosser T, Enrique N, Silva AJ, Allen GI, Bookheimer SY, Bearden CE.

Hum Brain Mapp. 2015 Nov;36(11):4566-81. doi: 10.1002/hbm.22937.

18.

The need for novel informatics tools for integrating and planning research in molecular and cellular cognition.

Silva AJ, Müller KR.

Learn Mem. 2015 Aug 18;22(9):494-8. doi: 10.1101/lm.029355.112. Review. Erratum in: Learn Mem. 2016 Oct 17;23 (11):668.

19.

Prioritizing the development of mouse models for childhood brain disorders.

Ogden KK, Ozkan ED, Rumbaugh G.

Neuropharmacology. 2016 Jan;100:2-16. doi: 10.1016/j.neuropharm.2015.07.029. Review.

20.

Using the spatial learning index to evaluate performance on the water maze.

Tomás Pereira I, Burwell RD.

Behav Neurosci. 2015 Aug;129(4):533-9. doi: 10.1037/bne0000078. Review.

Supplemental Content

Support Center